z-logo
open-access-imgOpen Access
Predictive value of ADC mapping in discriminating probably benign and suspicious breast lesions
Author(s) -
Mohamed Hamed Abowarda,
Doaa Ibrahim Hasan,
Osama Abdelaziz Elteeh
Publication year - 2015
Publication title -
the egyptian journal of radiology and nuclear medicine /the egyptian journal of radiology and nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 13
eISSN - 2090-4762
pISSN - 0378-603X
DOI - 10.1016/j.ejrnm.2015.02.004
Subject(s) - medicine , effective diffusion coefficient , radiology , predictive value , bi rads , breast imaging , breast mri , nuclear medicine , breast cancer , mammography , magnetic resonance imaging , cancer
PurposeThe purpose of this study was to evaluate the usefulness of apparent diffusion coefficient (ADC value) in differentiating between probably benign breast lesions and, suspicious lesions (ACR-BIRADS categories 3 and 4 respectively).Patients and methodsBreast lesions meeting study criteria were identified on dynamic contrast enhanced (DCE)-MRI examinations in 48 women over the course of the study period for 2years. We found 27 (56.2%) of the cases probably benign as their BIRADS category 3 and the remaining 21 (43.7%) cases were category 4. Images were obtained with diffusion sensitizing gradients of 0 and 750mm2/s. The apparent diffusion coefficient (ADC) was calculated and correlated with the histological data.ResultsThe ADC values recorded a sensitivity of 97.9% and a specificity of 80%. The positive predictive value was 95.7% in differentiation between the benign and suspicious breast lesions. The difference in mean ADC for benign breast lesions (BIRADS-3, 1.45±0.46×10−3mm2/s), and suspicious lesions (BIRADS-4, 1.06±0.56×10−3mm2/s) was statistically significant.ConclusionIncluding the ADC diffusion coefficient in the diagnostic work up of patients with indeterminate breast lesions can help in the differentiation between benign and malignant breast lesions

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here